In CRISPR perturbation and RNAi cell viability screens (DepMap portal), RUNX1 was identified as a strongly selective/high-dependency gene, especially in B-lymphoblastic leukemia/lymphoma cell lines. This evidence concerns the gene RUNX1 and lymphoma.